
Alchemy Secures $31M Seed Funding Led by a16z to Expand In-House Pharmacy Platform
Key Highlights
- $31M seed financing led by a16z Bio + Health
- Alchemy to expand in-house pharmacy programs across 20 states
- Focus on serving HIV and Hepatitis C (HCV) patient populations
- Partnerships with FQHCs, STD, and Ryan White clinics
- Alchemy's platform to enhance patient care and clinic financial impact
Source: Direct
Notable Quotes
“ Investing in Alchemy is deeply personal, not only as a person living with HIV, but because I’ve witnessed firsthand the devastating impacts of HIV in our communities. ”
Earvin “Magic” Johnson, Chairman & CEO at Magic Johnson Enterprises
“ I’m convinced that the number one barrier to medication access for HIV patients is the friction that exists in navigating the US pharmacy system. ”
Peter Park, Founder and Co-CEO at Alchemy
“ The Alchemy team has a proven track record building for challenging and underserved communities, and we're looking forward to supporting them. ”
Julie Yoo, General Partner at a16z Bio + Health